InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.84
(
-0.09%
)
Bitcoin
57,166.54
(
-4.98%
)
Post# of 252482
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119978
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: turtlepower post# 83384

Wednesday, 09/09/2009 5:25:16 PM

Wednesday, September 09, 2009 5:25:16 PM

Post# of 252482
VVUS:

…Qnexa uses the perfect combination of both generics and probably has a patent for the combination. Could be a problem down the road given the rigid obviousness guidelines patents are assessed with these days.

The problem for VVUS is not the potential invalidation of the “use” patent but rather that VVUS has no practical way to enforce the patent. Whom would VVUS sue if doctors write prescriptions for the two generic constituents?


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up